More than half of the S&P 500 is projected to rise by 8 percent in 12 months, according to analysts. Here are the stocks that could rise the most.» Read More
Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.
U.S. stocks closed lower, giving back most of Monday's major gains, as investors eyed mixed economic data and the end of the first quarter.
Global dealmaking is its fastest since 2007, with the value of deals struck in the first three months of 2015 up 21 per cent year on year to $811B, the Financial Times reports.
Jim Cramer sees money flowing in like crazy to the market on Monday, thanks to these two catalysts.
*China shares hit seven-year high on ambitious Silk Road project. Also Monday, Israel's Teva Pharmaceutical Industries said it would buy U.S. biopharmaceutical firm Auspex Pharmaceuticals Inc for $3.5 billion, and Ireland's Horizon Pharma Plc agreed to buy U.S. drugmaker Hyperion Therapeutics Inc for about $1.1 billion. Earlier, China unveiled details of an...
U.S. stocks closed more than 1 percent higher on Monday amid encouraging talk of stimulus in Asia, as investors eyed the week's economic data.
NEW YORK, March 30- UnitedHealth Group Inc's planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up. The $12.8 billion deal comes at a time when Wall Street has been parsing the possibilities that top insurers...
*UnitedHealth unit to buy Catamaran; Horizon to buy Hyperion. Among the deal news, OptumRx Corp, a unit of UnitedHealth Group, agreed to buy pharmacy benefit manager Catamaran Corp in a deal worth $12.78 billion. Shares of UnitedHealth, a Dow component, rose 2.7 percent to $121.17 while U.S. shares of Catamaran added 24 percent to $60.12.
This year is on track to surpass the record set in 2014 for M&A. "Merger Monday" is back. Here's how to trade it.
*UnitedHealth unit to buy Catamaran; Horizon to buy Hyperion. NEW YORK, March 30- U.S. stocks rallied more than 1 percent on Monday, with biotech stocks among the most active names amid a number of major deals in the space. Stock markets will be closed for the Good Friday holiday, leaving investors unable to trade on the jobs data until the following week.
Markets kicked off the week strong, with health care deals and anticipation of more stimulus in China moving global stocks.
*M&A deal lifts sentiment; UnitedHealth unit to buy Catamaran. Oil prices volatile amid potential deal with Iran. Despite that, energy shares could come under pressure as crude oil fell on a possible deal with Iran, which could bring an end to sanctions and allow an increase in the country's oil exports.
U.S. stock index futures indicated a sharply higher open on Monday, following European stocks' move upwards, ahead a data-packed week.
March 30- Health insurer UnitedHealth Group agreed to buy Catamaran Corp in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.. As employers look to cut prescription costs on expensive drugs, the deal with Catamaran will give UnitedHealth's pharmacy benefits unit,...
Some of the names on the move ahead of the open.
*M&A deal lifts sentiment; UnitedHealth unit to buy Catamaran. NEW YORK, March 30- U.S. stock index futures rose on Monday, pointing to a second straight daily gain as a trio of M&A deals lifted sentiment after a recent bout of weakness. *In deal news, OptumRx Corp, a unit of UnitedHealth Group, agreed to buy pharmacy benefit manager Catamaran Corp in a deal worth $12.78...
March 30- Health insurer UnitedHealth Group unit OptumRx Corp agreed to buy pharmacy benefit manager Catamaran Corp in a deal worth about $12.8 billion. UnitedHealth's offer of $61.50 per share represents a premium of 27 percent to Catamaran's Friday close on the Nasdaq. Catamaran's stock was trading at $60.50 premarket on Monday, while UnitedHealth's was...
UnitedHealth Group unit OptumRx Corp agreed to buy pharmacy benefit manager Catamaran Corp in a deal worth $12.78 billion.
March 30- UnitedHealth Group unit OptumRx Corp agreed to buy pharmacy benefit manager Catamaran Corp in a deal worth $12.78 billion.
U.S. stocks closed mildly higher as investors digested Fed Chair Janet Yellen's remarks remained cautious ahead of first quarter earnings in April.